Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. ("Nexien" or the "Company") (OTCQB: NXEN), a next...
DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. ("Nexien" or the "Company") (OTCQB: NXEN), a next...
Venture capital group announces the launch of its new fund, Hypur Ventures II, that will invest up to $500MM into...
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Cova is the point-of-sale (POS) solution of choice for nearly every...
DENVER, CO / ACCESSWIRE / March 28, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
Company to Capitalize on $16.7 Billion Telehealth Market by Offering Patient Directed Testing Through an Independent Provider Network TORONTO, ON...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Recently announced interim HS-110 Phase 2 data demonstrating survival benefit in patients with ‘cold' tumors (CD8+ TILs < 10% at...
- Combination Synergistic Even in Cells That Have Developed Resistance to Bortezomib - Article Published in the March 12 Edition...
SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
- EXCELLENCE IN SCIENCE, PARTNERED DRUG DISCOVERY & DEVELOPMENT, ACQUISITIONS, AND UNIQUE PLATFORM TECHNOLOGIES LEAD TO STRONG GROWTH MOMENTUM -...